mrx0518
Showing 1 - 3 of 3
Pancreatic Cancer Trial in Houston (MRx0518, Hypofractionated Preoperative Radiation)
Active, not recruiting
- Pancreatic Cancer
- MRx0518
- Hypofractionated Preoperative Radiation
-
Houston, TexasMD Anderson Cancer Center
Jul 5, 2022
Urothelial Carcinoma Trial in Irvine, Dallas, Houston (MRx0518, Avelumab 20 mg/mL Intravenous Solution (IV))
Active, not recruiting
- Urothelial Carcinoma
- MRx0518
- Avelumab 20 mg/mL Intravenous Solution (IV)
-
Irvine, California
- +2 more
Jul 5, 2022
Oncology, Solid Tumor, Non Small Cell Lung Cancer Trial in United States (MRx0518, Pembrolizumab 25 MG/1 ML Intravenous Solution
Active, not recruiting
- Oncology
- +5 more
- MRx0518
- Pembrolizumab 25 MG/1 ML Intravenous Solution [KEYTRUDA]
-
Kansas City, Kansas
- +4 more
Jul 5, 2022